Description: Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.
Home Page: windtreetx.com
WINT Technical Analysis
2600 Kelly Road
Warrington,
PA
18976-3622
United States
Phone:
215 488 9300
Officers
| Name | Title |
|---|---|
| Mr. Craig E. Fraser | Pres, CEO & Director |
| Mr. John P. Hamill CPA | Sr. VP, CFO, Treasurer & Corp. Sec. |
| Dr. Steven G. Simonson | Sr. VP & Chief Medical Officer |
| Mr. Eric L. Curtis M.B.A. | Sr. VP & COO |
| Mr. George Cox | VP of Technical Operations |
| Ms. Diane Carman Esq. | Sr. VP & Gen. Counsel |
| Dr. Pratap Paruchuru | Exec. Director of Clinical Devel. |
| Ms. Tracy Rarick | Head of Operations & Program Management |
| Dr. Ronald L. Dundore | Exec. Director of Regulatory Affairs & Quality |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.3959 |
| Price-to-Sales TTM: | 660.5268 |
| IPO Date: | 1995-08-08 |
| Fiscal Year End: | December |
| Full Time Employees: | 33 |